Home amgen
 

Keywords :   


Tag: amgen

Sandoz Inc. v. Amgen Inc.,

2015-02-16 16:58:53| Biotech - Topix.net

Case Name: Sandoz Inc. v. Amgen Inc., No. 2014-1693, 2014 U.S. App. LEXIS 22903 Drug Product and Patent -in-Suit: Enbrel ; U.S. Pats.

Tags: inc amgen sandoz

 

Amgen: Its biosimilar version of Humira about as effective

2015-02-04 00:09:02| Biotech - Topix.net

Biologic drugmaker Amgen says its biosimilar version of rheumatoid arthritis drug Humira worked similarly in a key head-to-head test. Amgen Inc. says its ABP 501 produced similar results in the percentage of patients in the 26-week, late-stage study who saw improvements in pain, ability to function and number of swollen and tender joints.

Tags: version effective amgen humira

 
 

Amgen tops Street 4Q forecasts

2015-01-28 02:07:54| Biotech - Topix.net

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit. The world's biggest biotech drugmaker by revenue said it's starting a cycle of several important new product launches - big enough that last year it announced major job reductions and other cost cuts to free up money for the launches.

Tags: street tops forecasts amgen

 

I'm Waiting Till The Carnage In Biotech Stocks Subsides To Buy Amgen

2014-12-26 15:08:16| Biotech - Topix.net

There has definitely been a sector rotation out of biotech stocks and into the consumer goods names that pay high dividend yields. The last time I analyzed Amgen Inc. on November 25, 2014, I stated, "More than likely I'll be waiting till 2015 to buy any more batches in the name, because it has run up just too high in such a short time."

Tags: to buy till waiting

 

Addition Of Amgen Drug Boosts Benefits In Relapsed Myeloma: Study

2014-12-08 09:04:12| Biotech - Topix.net

Significantly more patients with relapsed multiple myeloma responded to a three-drug regimen including Amgen Inc's Kyprolis than those who got the standard two-drug treatment, according to results from a late-stage trial. Patients with the blood cancer who received the Kyprolis regimen for 18 months also had a longer duration of response and reported better health-related quality of life, data presented on Saturday showed.

Tags: addition study benefits drug

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »